"[4BA54ECD92EF]" . . "14" . . "Zav\u0159elov\u00E1, A." . "Z(MO0FVZ0000503), Z(MZ0FNHK2005)" . "V na\u0161em souboru pacient\u016F jsme zaznamenali velmi n\u00EDzkou incidenci rozvoje sMDS/AML po prod\u011Blan\u00E9 ASCT pro lymfom s pou\u017Eit\u00EDm p\u0159\u00EDpraven\u00E9ho re\u017Eimu BEAM. Zji\u0161t\u011Bn\u00E1 hrub\u00E1 incidence v souboru \u010Din\u00ED 2,5% a 5let\u00E1 kumulativn\u00ED incidence 3%." . "Transfuze a hematologie dnes" . "Therapy-related MDS/AML after autlogous stem cell transplantation for lymphoma with BEAM as conditioning: our experience"@en . . . . "Sekund\u00E1rn\u00ED MDS/AML po autologn\u00ED transplantaci pro lymfom s pou\u017Eit\u00EDm BEAM jako p\u0159\u00EDpravn\u00E9ho re\u017Eimu: zku\u0161enosti jednoho pracovi\u0161t\u011B"@cs . "myelodysplastic syndrome; secondary leukemia; autologous stem cell transplantation"@en . "Therapy-related MDS/AML after autlogous stem cell transplantation for lymphoma with BEAM as conditioning: our experience"@en . "Mal\u00FD, J." . "B\u011Blohl\u00E1vkov\u00E1, P." . . "V na\u0161em souboru pacient\u016F jsme zaznamenali velmi n\u00EDzkou incidenci rozvoje sMDS/AML po prod\u011Blan\u00E9 ASCT pro lymfom s pou\u017Eit\u00EDm p\u0159\u00EDpraven\u00E9ho re\u017Eimu BEAM. Zji\u0161t\u011Bn\u00E1 hrub\u00E1 incidence v souboru \u010Din\u00ED 2,5% a 5let\u00E1 kumulativn\u00ED incidence 3%."@cs . "394118" . "RIV/60162694:G44__/08:00002063" . "Belada, D." . "8"^^ . "Sekund\u00E1rn\u00ED MDS/AML po autologn\u00ED transplantaci pro lymfom s pou\u017Eit\u00EDm BEAM jako p\u0159\u00EDpravn\u00E9ho re\u017Eimu: zku\u0161enosti jednoho pracovi\u0161t\u011B"@cs . "\u017D\u00E1k, P." . "5"^^ . . "G44" . . . "CZ - \u010Cesk\u00E1 republika" . "1" . "RIV/60162694:G44__/08:00002063!RIV09-MO0-G44_____" . "Sekund\u00E1rn\u00ED MDS/AML po autologn\u00ED transplantaci pro lymfom s pou\u017Eit\u00EDm BEAM jako p\u0159\u00EDpravn\u00E9ho re\u017Eimu: zku\u0161enosti jednoho pracovi\u0161t\u011B" . "Jebav\u00FD, Ladislav" . "Sekund\u00E1rn\u00ED MDS/AML po autologn\u00ED transplantaci pro lymfom s pou\u017Eit\u00EDm BEAM jako p\u0159\u00EDpravn\u00E9ho re\u017Eimu: zku\u0161enosti jednoho pracovi\u0161t\u011B" . "1"^^ . . . . "Vogelov\u00E1, J." . . . . "Cermanov\u00E1, M." . . "In our single center retrospective analysis we detected low incidence of tMDS/AML after ASCT with BEAM as the conditioning regimen. The crude incidence was 2,5% and 5-year cumulative indicence was 3%."@en . "1213-5763" .